|
1
|
Linzer DI and Levine AJ: Characterization
of a 54K Dalton cellular SV40 tumor antigen present in
SV40-transformed cells and unifected embryonal carcinoma cells.
Cell. 17:43–52. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lane DP: Cancer. p53, guardian of the
genome. Nature. 358:15–16. 1992. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lane DP, Stephen CW, Midgley CA, Sparks A,
Hupp TR, Daniels DA, Greaves R, Reid A, Vojtesek B and Picksley SM:
Epitope analysis of the murine p53 tumour suppressor protein.
Oncogene. 12:2461–2466. 1996.PubMed/NCBI
|
|
4
|
Kastan MB, Onyekwere O, Sidransky D,
Vogelstein B and Craig RW: Participation of p53 protein in the
cellular response to DNA damage. Cancer Res. 51:6304–6311.
1991.PubMed/NCBI
|
|
5
|
Hartwell L: Defects in a cell cycle
checkpoint may be responsible for the genomic instability of cancer
cells. Cell. 71:543–546. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Unger T, Nau MN, Segal S and Minna JD:
p53: a transdominant regulator of transcription whose function is
ablated by mutations occurring in human cancer. EMBO J.
11:1383–1390. 1992.PubMed/NCBI
|
|
7
|
Clarke AR, Purdie CA, Harrison DJ, Morris
RG, Bird CC, Hooper ML and Wyllie AH: Thymocyte apoptosis induced
by p53-dependent and -independent pathways. Nature. 362:849–852.
1993. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hall PA, Mckee PH, Du P, Manage H, Dover R
and Lane DP: High levels of p53 protein in UV-irradiated normal
human skin. Oncogene. 8:203–207. 1993.PubMed/NCBI
|
|
9
|
Hall PA and Lane DP: Tumour supressors: a
developing role for p53? Curr Biol. 7:R144–R147. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Teodoro JG, Evans SK and Green MR:
Inhibition of tumor angio-genesis by p53: a new role for the
guardian of the genome. J Mol Med. 85:1175–1186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sah VP, Attardi LD, Mulligan GJ, Williams
BO, Bronson RT and Jacks T: A subset of p53-deficient embryos
exhibit exencephaly. Nat Genet. 10:175–180. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matoba S, Kang JG, Patino WD, Wragg A,
Boehm M, Gavrilova O, Hurley PJ, Bunz F and Hwang PM: p53 regulates
mitochondrial respiration. Science. 312:1650–1653. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Erster S and Moll UM: Stree-induced p53
runs a transcription-independent death program. Biochem Biophys Res
Commun. 331:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mihara M, Erster S, Zaika A, Petrenko O,
Chittenden T, Pancoska P and Moll UM: p53 has a direct apoptogenic
role at the mitochondria. Mol Cell. 11:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Murphy ME, Leu JI and George DL: p53 moves
to mitochondria: a turn on the path to apoptosis. Cell Cycle.
3:836–839. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bonini P, Cicconi S, Cardinale A, Vitale
C, Serafino AL, Ciotti MT and Marlier LN: Oxidative stress induces
p53-mediated apoptosis in glia: p53 transcription-independent way
to die. J Neurosci Res. 75:83–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tendler Y, Weisinger G, Coleman R, Diamond
E, Lischinsky S, Kerner H, Rotter V and Zinder O: Tissue-specific
p53 expression in the nervous system. Brain Res Mol Brain Res.
72:40–46. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tendler Y, Panshin A, Weisinger G and
Zinder O: Identification of cytoplasmic p53 protein in corneal
epithelium of vertebrates. Exp Eye Res. 82:674–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pokroy R, Tendler Y, Pollack A, Zinder O
and Weisinger G: p53 expression in the normal murine eye. Invest
Ophthalmol Vis Sci. 43:1736–1741. 2002.PubMed/NCBI
|
|
21
|
Estil S, Kravik K, Haaskjold E, Refsum SB,
Bjerknes R and Wilson G: Pilot study on the time course of
apoptosis in the regenerating corneal epithelium. Acta Ophthalmol
Scand. 80:517–523. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ren H and Wilson G: The effect of
ultraviolet-B irradiation on the cell shedding rate of the corneal
epithelium and changes of p53 expression. Acta Ophthalmol.
72:447–452. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ren H and Wilson G: Apoptosis in the
corneal epithelium. Invest Ophthalmol Vis Sci. 37:1017–1025.
1996.PubMed/NCBI
|
|
24
|
Lomako J, Lomako WM, Decker SJ, Carraway
CA and Carraway KL: Non-apoptotic desquamation of cells from
corneal epithelium: putative role for Muc4/sialomucin complex in
cell release and survival. J Cell Physiol. 202:115–124. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wade-Evans A and Jenkins JR: Precise
epitope mapping of the murine transformation-associated protein,
p53. EMBO J. 4:699–706. 1985.PubMed/NCBI
|
|
26
|
Yewdell JW, Gannon JV and Lane DP:
Monoclonal antibody analysis of p53 expression in normal and
transformed cells. J Virol. 59:444–452. 1986.PubMed/NCBI
|
|
27
|
Yin X, Fontoura B, Morimoto T, Robert B
and Carroll RB: Cytoplasmic complex of p53 and eEF2. J Cell
Physiol. 196:474–482. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Arai N, Nomura D, Yokota K, Wolf D, Brill
E, Shohat O and Rotter V: Immunologically distinct p53 molecules
generated by alternative splicing. Mol Cell Biol. 6:3232–3239.
1986.PubMed/NCBI
|
|
29
|
Gavrieli Y, Sherman Y and Ben-Sasson SA:
Identification of programmed cell death in situ via specific
labelling of nuclear DNA fragmentation. J Cell Biol. 119:493–501.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sambrook J, Fritsch EF and Maniatis T:
Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring
Harbor Laboratory Press; New York: pp. 1834–1874. 1989
|
|
32
|
Almog N, Li R, Peled A, Schwartz D,
Wolkowicz R, Goldfinger N, Pei H and Rotter V: The murine
C’-terminal alternatively spliced form of p53 induces attenuated
apoptosis in myeloid cells. Mol Cell Biol. 17:713–722. 1997.
|
|
33
|
Liu S, Li J, Tao Y and Xiao X: Small heat
shock protein alphaB-crystallin binds to p53 to sequester its
translocation to mitochondria during hydrogen peroxide-induced
apoptosis. Biochem Biophys Res Commun. 354:109–114. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grueterich M, Alge C, Fuchs A, Kampik A
and Welge-Luessen U: Alpha-B-crystallin in the limbal and corneal
epithelium. Invest Ophthalmol Vis Sci. 44E:13582003.
|
|
35
|
Shaulsky G, Goldfinger N, Tosky M, Levine
AJ and Rotter V: Nuclear localization is essential for the activity
of p53 protein. Oncogene. 6:2055–2065. 1991.PubMed/NCBI
|
|
36
|
Bean LJ and Stark GR: Phosphorylation of
serines 15 and 37 is necessary for efficient accumulation of p53
following irradiation with UV. Oncogene. 20:1076–1084. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Qin JZ, Chaturvedi V, Denning MF, Bacon P,
Panella J, Choubey D and Nickoloff BJ: Regulation of apoptosis by
p53 in UV-irradiated human epidermis, psoriatic plaques and
senescent keratinocytes. Oncogene. 21:2991–3002. 2002. View Article : Google Scholar : PubMed/NCBI
|
